Skip to main content

FDA identifies recall of ResMed's respiratory devices as most serious

Submitted by admin on
snippet

The U.S. Food and Drug Administration (FDA) on Thursday classified the recall of certain respiratory masks made by ResMed (RMD.N) as most serious as their use could cause major injuries or death.

Source
Reuters

Has ResMed Hit Its Peak?

Submitted by admin on
snippet

The big unknown in the sleep apnea world continues to be when Philips will re-enter the market. ResMed has more than risen to the challenge of meeting unprecedented demand in the competitor's absence, but now medtech analysts are wondering if ResMed's sleep apnea market share gains are peaking.

Source
Medical Devices and Diagnostics Industry

Big medtechs’ efficiency starts to recover from Covid

Submitted by admin on
snippet

The sales a medtech company reaps per worker it employs is not the only measure of its efficiency, but it can be useful. It certainly highlights the tribulations of the sector through Covid, with 2021’s data indicating a major recovery in revenues and market cap among orthopaedics and cardiology companies.

It is still Intuitive Surgical that reigns supreme on this measure, however. At $490,000 in 2021 the robotic surgery leader’s sales per employee have ticked up from 2020 as lockdowns lifted and hospitals reopened for non-emergency procedures. This figure is still 4% lower than pre-pandemic 2019’s number, though, so the company has more ground yet to regain.

Source
EP Vantage

ResMed, Google sibling Verily form digital health venture to improve access to sleep treatment

Submitted by admin on
snippet

ResMed and Verily have formed a joint venture to provide personalized care to address sleep disorders.
The venture, named Primasun, will screen people online, connect them virtually to sleep specialists and provide at-home testing, treatment and personalized coaching as needed.

Source
Medtech Dive

ResMed Wants Philips Back in the CPAP Game

Submitted by admin on
snippet

As Philips continues to work through its massive recall initiated 15 months ago impacting ventilators and sleep apnea devices, ResMed continues working to keep up with excess demand for CPAP (continuous positive airway pressure) devices created by the competitor's recall.

Source
Medical Devices and Diagnostics Industry

ResMed Strengthens Sleep Portfolio with Mementor Acquisition

Submitted by admin on
snippet

ResMed yesterday announced the acquisition of Leipzig, Germany-based company, mementor, which the company is hopeful will strengthen its overall sleep portfolio in the country. mementor, which was founded in 2014, owns the digital insomnia therapy solution, somnio.

Source
Medical Devices and Diagnostics Industry

ResMed Converts High Demand for Sleep Apnea Machines into High-Value M&A

Submitted by admin on
snippet

The “unlimited demand” for ResMed’s sleep apnea machines has given the San Diego, CA-based company the capital to become involved in some heavy-duty M&A. ResMed said it had signed a definitive agreement to acquire Medifox Dan for about $1 billion.

Source
Medical Devices and Diagnostics Industry

These medtech stocks performed the best in 2020

Submitted by admin on
snippet

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — has hit new heights over the course of 2020, indicating the upward trajectory of the industry. Over the course of the year, the index grew from a total of $86.86 to $104.55, representing a 20.4% increase.

Outside of the pharmaceutical space, many medtech companies experienced their own blossoming on the markets. Here are some of the top performing medtech stocks over the course of the crazy year that was 2020

Source
Medtech Dive

8 largest FDA recalls of 2020

Submitted by admin on
snippet

Medical device and drug recalls, whether voluntary or mandated by the FDA, ensure patient safety. Over the course of 2020, several large-scale recalls of medical devices, supplies and drugs have taken place. 

Source
Beckers Hospital Review